Home > Boards > Free Zone > Penny Trading - Technical > $.0001-$.0011 News, DDs & Charts Only!!!

pipeline, revenue growth, and recent developments on an

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
mick Member Profile
Member Level 
Followed By 2,615
Posts 857,185
Boards Moderated 199
Alias Born 09/04/00
160x600 placeholder
mick Member Level  Saturday, 10/12/19 02:17:57 PM
Re: mick post# 47211
Post # of 47529 
pipeline, revenue growth, and recent developments on an exclusive call with CEO Dr. Gary Jacob this Thursday, September 26, at 4 pm ET. Dr. Jacob will give a 15-minute presentation and then the call will be opened to questions from the audience.



Call information:

Sept. 26 at 4 pm ET /1 pm PT

Conference Line: (866) 821-0302**

**U.S. only. Contact us at info@redchip.com for dial-in info for investors outside U.S.



The Background: IMRN is an Australian biopharma focused on developing and commercializing orally delivered polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases. The Company currently markets Travelan in Australia, Canada, and the U.S. IMRN’s lead clinical drug candidate, IMM-124E, is presently in Phase II trials in severe alcoholic hepatitis (ASH) and pediatric non-alcoholic fatty liver disease (NAFLD), and the Company recently announced plans to pursue clinical development of IMM-124E through a formal FDA registration pathway as a drug to specifically prevent travelers’ diarrhea. IMRN’s second clinical-stage asset, IMM-529, targets Clostridium difficile infections (CDI), and is presently in a clinical trial in CDI patients. The Company is expected to file an IND with the FDA in the near-term targeting treatment of recurrent CDI.



Disclosure

Immuron Ltd. (NASDAQ: IMRN) is a client of RedChip Companies, Inc. IMRN agreed to pay RedChip Companies, Inc. a monthly cash fee for (3) months of investor awareness services.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist